These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7705668)

  • 1. Increased cathepsin L levels in serum in some patients with ovarian cancer: comparison with CA125 and CA72-4.
    Nishida Y; Kohno K; Kawamata T; Morimitsu K; Kuwano M; Miyakawa I
    Gynecol Oncol; 1995 Mar; 56(3):357-61. PubMed ID: 7705668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of determining tumor markers CEA, CA125 and CA72-4 in blood serum of patients with ovarian carcinoma].
    Kokocińska D; Worwag J; Tomala J; Dzieciuchowicz L; Nowak S; Kuśmierski S
    Ginekol Pol; 1994 Sep; 65(9):495-501. PubMed ID: 7721162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer.
    Bian J; Li B; Kou XJ; Liu TZ; Ming L
    Asian Pac J Cancer Prev; 2013; 14(11):6241-3. PubMed ID: 24377511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer.
    Granato T; Midulla C; Longo F; Colaprisca B; Frati L; Anastasi E
    Tumour Biol; 2012 Oct; 33(5):1335-9. PubMed ID: 22528938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?
    Anastasi E; Manganaro L; Granato T; Benedetti Panici P; Frati L; Porpora MG
    Dis Markers; 2013; 35(5):331-5. PubMed ID: 24191126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer.
    Fayed ST; Ahmad SM; Kassim SK; Khalifa A
    Dis Markers; 1998 Nov; 14(3):155-60. PubMed ID: 10427474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
    Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J
    Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients.
    Fioretti P; Gadducci A; Ferdeghini M; Prontera C; Malagnino G; Facchini V; Mariani G; Bianchi R
    Gynecol Oncol; 1992 Feb; 44(2):155-60. PubMed ID: 1544592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application value of the detection of the level of tissue polypeptide antigen, ovarian cancer antigen X1, cathepsin L and CA125 on the diagnosis of epithelial ovarian cancer.
    Lv XL; Zhu Y; Liu JW; Ai H
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5113-5116. PubMed ID: 28051260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis.
    Imai A; Horibe S; Takagi A; Takagi H; Tamaya T
    Eur J Obstet Gynecol Reprod Biol; 1998 May; 78(1):79-81. PubMed ID: 9605454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
    Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum mesothelin in malignant and benign ovarian masses.
    Ibrahim M; Bahaa A; Ibrahim A; El Hakem AA; Abo-El Noor A; El Tohamy U
    Arch Gynecol Obstet; 2014 Jul; 290(1):107-13. PubMed ID: 24445964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis.
    Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Carroccio A; Ippolito S; Gebbia N
    Pancreas; 1997 Jan; 14(1):22-7. PubMed ID: 8981503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
    Kobayashi H; Sumimoto K; Terao T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.
    Hareyama H; Sakuragi N; Makinoda S; Fujimoto S
    J Clin Pathol; 1996 Dec; 49(12):967-70. PubMed ID: 9038731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.